Paper · 312265
Antagonistic interactions between enhancing and suppressor factors that regulate the humoral immune response.
Rubin AS. Immunology, 1979. Cited by 10 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Antagonistic interactions between enhancing and suppressor factors that regulate the humoral immune response. Papers, record 312265. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/312265
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antagonistic interactions between enhancing and suppressor factors that regulate the humoral immune response.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibody Formation | Major topic |
| T-Lymphocytes | Major topic |
| Animals | |
| B-Lymphocytes | |
| Cells, Cultured | |
| Colony-Forming Units Assay | |
| Female | |
| Lymphocyte Cooperation | |
| Mice | |
| Mice, Inbred Strains | |
| Spleen |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 75,231 | Antigen-specific T-cell-mediated suppression. I. Induction of L-glutamic acid60-L-alanine30-L-tyrosine10 specific suppressor T cells in vitro requires both antigen-specific T-cell-suppressor factor and antigen. | J Exp Med | 1978 | https://conductscience.org/library/papers/75231 | PubMed |
| 2 | 338,477 | Partial characterization of a T cell-derived factor that suppresses the initiation of the humoral immune response in vitro. | Immunology | 1977 | https://conductscience.org/library/papers/338477 | PubMed |
| 3 | 324,897 | Non-specific suppression of the initiation of the immune response to a heterologous immunogen by supernatants from specifically stimulated, primed lymphoid cells. | Immunology | 1977 | https://conductscience.org/library/papers/324897 | PubMed |
| 4 | 302,181 | The role of the histocompatibilty gene complex in lymphocyte defferetiation. | Cold Spring Harb Symp Quant Biol | 1977 | https://conductscience.org/library/papers/302181 | PubMed |
| 5 | 302,180 | The significance of T-B collaboration across haplotype barriers. | Cold Spring Harb Symp Quant Biol | 1977 | https://conductscience.org/library/papers/302180 | PubMed |
| 6 | 303,152 | Dual biological function of a T-cell-derived murine immunoenhancing factor. | Cell Immunol | 1977 | https://conductscience.org/library/papers/303152 | PubMed |
| 7 | 1,086,318 | Differences in the age-dependent release of a low molecular weight suppressor (LMWS) and stimulators by normal and nzb/w lymphoid organs. | J Immunol | 1976 | https://conductscience.org/library/papers/1086318 | PubMed |
| 8 | 4,116,319 | The regulatory influence of activated T cells on B cell responses to antigen. | Adv Immunol | 1972 | https://conductscience.org/library/papers/4116319 | PubMed |
| 9 | 4,118,414 | Specific heterologous enhancement of immune responses. IV. Specific generation of a thymus-derived enhancing factor. | J Exp Med | 1972 | https://conductscience.org/library/papers/4118414 | PubMed |
| 10 | 4,126,290 | Reconstitution of T cell-depleted spleen cell populations by factors derived from T cells. 3. Mechanism of action of T cell-derived factors. | J Immunol | 1973 | https://conductscience.org/library/papers/4126290 | PubMed |
1 to 10 of 36
See all 36 referencesCited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,972,349 | Polyclonal immunoglobulin synthesis induced by a macrophage factor acting via T cells. | Immunology | 1981 | https://conductscience.org/library/papers/6972349 | PubMed |
| 6,682,089 | Relationship between a spleen-derived immunosuppressive peptide 'SDIP' and the 'Facteur thymique sérique' (FTS): biochemical and biological comparison of the two factors. | Immunology | 1983 | https://conductscience.org/library/papers/6682089 | PubMed |
| 6,168,568 | Participation of diffusible products in the in vivo immune primary response to red blood cells. | Immunology | 1981 | https://conductscience.org/library/papers/6168568 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/312265
GET https://conductscience.org/api/papers/v1/312265/references?page=2